\
&
Contact us
\
&
Contact us
Published on | 2 years ago
ProgrammesThere is 1 attachment connected to this article.
Attachments are only accessible for people with an account on the NCP Flanders website.
The European Commission’s Directorate-General for Defence Industry and Space (DG DEFIS) has announced that the EDF Info Days 2024 gathered more than 3000 participants from all around the EU, Norway and beyond both on-site and online.
It was a unique opportunity to learn all what is needed to apply to EDF 2024 calls for proposals and to discover and network with potential partners in future EDF projects.
The slides of Day 1 (plenary info session) are now available here.
The recording of the event will soon be available.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space EIT Deployment: Best use of technologies
The Co-Creation Accelerator is a programme run by 28DIGITAL (formerly EIT Digital). It brings together start-ups and industry partners to co-develop solutions to real-world challenges, with a focus on: Validating core technology (TRL 4-5 and above) Strengthening problem-solution fit Reducing technical and market uncertainty Building a cle... read more
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
